Reprogramming Rotavirus: Reverse Genetics-Driven Design of Viral Vector Platforms
Viruses · 09.06.2026 · 18 (6) · 655
DOI: 10.3390/v18060655 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 09.06.2026. Verfasst von Ke Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Medical Virology and Viral Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Na…. Hauptthemen laut MEDLINE: Reverse Genetics, Rotavirus, Genetic Vectors, Rotavirus Infections. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Rotaviruses remain the leading cause of severe dehydrating diarrhea and associated mortality in children under five years of age worldwide. The successful global rollout of live-attenuated oral rotavirus vaccines has dramatically reduced rotavirus gastroenteritis morbidity and mortality, unequivocally demonstrating their excellent safety profile and potent induction of mucosal immunity. These attributes highlight the substantial potential of rotaviruses as novel oral mucosal vaccine vectors. Recent breakthroughs in reverse genetics, particularly the establishment of a fully plasmid-based system in 2017, have enabled precise insertion and stable expression of foreign antigens at targeted genomic loci. This advance has opened a viable pathway for developing multivalent oral mucosal vaccines. This review traces the historical development of rotavirus reverse genetics and summarizes the latest progress in its application as a vaccine vector platform. We focus on key strategies for foreign gene insertion and immunological outcomes in animal models, while critically evaluating persistent challenges—virus rescue efficiency, genetic stability of inserts, and limitations of current animal models—and outlining the rational design framework for RV-based vectors with improved stability, expression efficiency, and immunogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Medical Virology and Viral Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Cen…
- School of Public Health, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China.
- The First Clinical Medical Institute, Henan University of Chinese Medicine, Zhengzhou 450000, China.
- CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
- Center for Drug Evaluation, National Medical Products Administration, Beijing 100163, China.
ORCID-Profile: Pengdi Chai, Zhaojun Duan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, K., Wei, X., Ouyang, X., Liu, X., Chai, P., Bai, Y., & Duan, Z. (2026). Reprogramming Rotavirus: Reverse Genetics-Driven Design of Viral Vector Platforms. Viruses, 18(6), 655. https://doi.org/10.3390/v18060655
Vancouver
Li K, Wei X, Ouyang X, Liu X, Chai P, Bai Y, et al. Reprogramming Rotavirus: Reverse Genetics-Driven Design of Viral Vector Platforms. Viruses. 2026;18(6):655. doi:10.3390/v18060655
BibTeX
@article{Li2026,
author = {Li, Ke and Wei, Xiao and Ouyang, Xuanze and Liu, Xiafei and Chai, Pengdi and Bai, Yu and Duan, Zhaojun},
title = {Reprogramming Rotavirus: Reverse Genetics-Driven Design of Viral Vector Platforms},
journal = {Viruses},
year = {2026},
volume = {18},
number = {6},
pages = {655},
doi = {10.3390/v18060655}
}
EUVIMED